NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare ConferenceGlobeNewsWire • 08/29/19
NuCana Reports Second Quarter 2019 Financial Results and Provides Business UpdateGlobeNewsWire • 08/21/19
NuCana stock falls 21% after company suspends patient enrollment in pancreatic cancer trialMarket Watch • 08/20/19
Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility AnalysisGlobeNewsWire • 08/20/19